Home › NDC Lookup › RxCUI directory › RxCUI 197855

Ketoprofen 50 MG Oral Capsule — RxCUI 197855

RxNorm drug concept · Semantic clinical drug
RxCUI 197855 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197855
Official nameKetoprofen 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ketoprofen: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ketoprofen is mainly used for rheumatoid arthritis and osteoarthritis — both the regular capsules (including Orudis) and the extended-release capsules cover those. The regular caps...
  • What conditions is ketoprofen actually prescribed for?
  • Either way works in terms of how much drug gets into your system — food doesn't change the total absorption. But taking it with food, milk, or even an antacid can ease stomach upse...
  • Should I take ketoprofen with food or on an empty stomach?
📖 Read our full Ketoprofen guide →

🕸️ Concept Web — How Ketoprofen 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ketoprofen 50 MG Oral Capsule RxCUI 197855

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ketoprofen 6142
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ketoprofen Oral Capsule 372535
    • Ketoprofen Oral Product 1160961
    • Ketoprofen Pill 1160962
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ketoprofen 50 MG 316119

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ketoprofen 50 MG SCDC · 316119
  • Ketoprofen Oral Capsule SCDF · 372535
  • Ketoprofen Oral Product SCDG · 1160961
  • Ketoprofen Pill SCDG · 1160962

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 197855 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00276-0504-10 100 CAPSULE in 1 BOTTLE (0276-0504-10) Ketoprofen Misemer Pharmaceuticals, Inc. 2021-11-01
00276-0506-10 100 CAPSULE in 1 BOTTLE (0276-0506-10) Ketoprofen Misemer Pharmaceuticals, Inc. 2022-09-13
00276-0507-10 100 CAPSULE in 1 BOTTLE (0276-0507-10) Ketoprofen Misemer Pharmaceuticals, Inc. 2025-05-23
85477-0111-01 100 CAPSULE in 1 BOTTLE (85477-111-01) Ketoprofen Oncora Pharma, LLC 2026-03-01
Observed labelers: Misemer Pharmaceuticals, Inc. (3) · Oncora Pharma, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.